Regulations/Policies - Express Pharma

Towards a healthier, more equitable and innovative Indian healthcare sector

MRP of 3 anti-cancer drugs to come down due to exemption from custom duty and reduction in GST

9th Advanced GMP Workshop 2024 was organised by IPA

International life sciences regulations: How CROs, CMOs, and CDMOs are primed for advantage

Critical to make a clear distinction between NSQ and Spurious Drugs: IPA

Industry hails Bio E3 policy as transformative for India’s biotech sector

Ministry of Science and Technology releases new BioE3 policy

Govt bans 156 FDCs with immediate effect

JP Nadda inaugurates First Policy Makers’ forum in New Delhi

Regulatory convergence is extremely important